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Keane and Freedman (1) demonstrated that diuresis produced by feeding 5%
glucose rendered mice susceptible to acute ascending pyelonephritis with Escher-
ichia coli. We reported the use of this model in therapeutic studies of E. coli (2)
and Proteus mirabilis (3) pyelonephritis. The present investigation, a bacteriologic,
immunologic, and pathologic study of long-term infection with E. coli shows that
pyelonephritis persisted and progressed for the duration of the study (32 wk).
MATERIALS AND METHODS
Animals. Random-bred male Swiss-Webster mice weighing 20-25 g were ob-
tained from local commerical sources.
Bacteria. Escherichia coli strain Yale, originally isolated from a patient with
urinary tract infection, was used.
Media. Brain-heart infusion broth and agar (Difco) were used. Blood agar base
(BBL) with 5% defibrinated sheep erythrocytes was used to grow the E. coli di-
rectly from infected kidneys during mouse passage to maintain virulence.
Production of diuresis. Experimental animals were fed 5% glucose in water ad
lib.; controls were given tap water ad lib. In addition, restriction of food to 4 g
per day per mouse (Purina-Ralston) was found to result in a lower urinary specific
gravity in diuresed mice. Therefore, both diuresed and nondiuresed mice were
provided only 4 g per day. Growth was normal; the mice approximately doubled
their body weight over the 32 wk of study. Diuresed animals were started on glu-
cose 1 wk before infection and continued so until sacrifice.
Production of pyelonephritis. Pyelonephritis was produced as previously de-
scribed (2). At time of sacrifice both kidneys were removed, homogenized sepa-
rately, serially diluted, and quantitatively assayed by plate count. Urine was as-
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pirated from the bladder, cultured, and specific gravity determined. Blood was
obtained from the heart at time of sacrifice, allowed to clot, serum separated, and
frozen at -200C within 3 hr.
Immunologic studies. Antibacterial antibody was measured by agglutination and
hemagglutination. Agglutinating antibodies were determined by serial dilution of
serum with live E. coli as antigen. Hemagglutinating antibody was measured using
as antigen sheep erythrocytes coated with extract prepared by boiling the bacteria.
In both studies, sera were diluted in 0.85% NaCl. End point in each instance was
the highest dilution of serum giving definite agglutination.
Serum bactericidal activity was done as previously described (4) by mixing in
final concentration per milliliter, 103 bacteria, 1:25 guinea pig complement (Hy-
land) and serial serum dilutions in minimal medium (5). Surviving bacteria were
determined by plate count after 1 hr incubation at 370C.
Antikidney antibody was measured against both saline (0.85% NaCl) extract
and specific soluble substance prepared from normal mouse kidney. Saline extract
was prepared by rinsing kidney slices in saline until free of visible blood, followed
by homogenization in 2 vol of saline. After overnight storage at 40C, debris was
removed by low-speed centrifugation and supernatant stored at -200C. Extract
was coated on tanned sheep erythrocytes and agglutination measured with incuba-
tion of serum serially diluted in 2% normal rabbit serum in 0.85% NaCl. Specific
soluble substance was prepared by the method of Cole et al. (6) and similarly
tested by coating on sheep erythrocytes.
Histologic study. At time of sacrifice, a slice of each kidney was placed in neutral
formalin and sections stained with hematoxylin eosin and periodic acid-Schiff.
Blood urea nitrogen (BUN): The blood urea nitrogen (BUN) was determined
by urea test kit (C. F. Boehringer and Soehne GMH).
RESULTS
Mice were sacrificed in groups of five to six from 1 to 32 wk after infection.
The results of bacteriologic examination are shown in Table 1. Overall one-half
TABLE 1
BACTERIOLOGIC FINDINGS AFTER INTRABLADDER INOCULATION OF Escherichia coli
YALE INTO MICE UNDERGOING DIURESIS
Time of Log number Proportion Log number Proportion
sacrifice Number bacteria/g kidneys with bacteria/ml urine with
(wk) animals kidneya bacteria urinea bacteria
1 6 4.34 ± 0.46 11/12 4.62 ± 1.18 6/6
4 6 4.14 ± 0.70 9/12 7.79 ± 0.06 3/6
8 6 4.67 ± 0.42 5/12 7.53 ± 0.35 3/6
12 5 4.25 ± 0.05 2/10 3.21- 1/5
16 5 6.10 ± 0.58 4/10 6.01 ± 2.54 3/5
20 5 4.36 ± 0.53 6/10 6.89 ± 0.45 3/5
24 6 7.16 ± 0.86 6/12 6.98 ± 0.44 3/6
28 6 4.42 ± 0.34 2/12 5.90 ± 3.01 2/6
32 6 5.73 ± 0.52 6/12 8.03 ± 0.04 3/6
Overall
times 51 5.02 ± 0.52 51/102 6.76 ± 1.00 27/51
a Infected kidneys or urine onily. At 12 wks only one urine had bacteria, no standard deviation
could be calculated.
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FIG. 1. Infected kidney, 1 wk. Infiltration of the pelvic epithelium by polymorphonuclear
leukocytes is observed. The subepithelial connective tissue is infiltrated by mononuclear cells.
x250.
of the kidneys were infected. Bacteria persisted in high numbers in the infected
kidneys and urine and the proportion of infected kidneys was unchanged for the
duration of the study, 32 wk. Twenty three of 51 mice had both kidneys infected
and five had unilateral infection. Among the 28 animals with bacteria in one or both
kidneys, 25 had bacteriuria while three (all with unilateral infection) had sterile
urine. Two animals had bacteriuria without bacteria in the kidney.
The earliest pathological change observed in the infected kidneys was infiltration
of the pelvic ephithelium and subepithelial connective tissue by mononuclear cells
and polymorphonuclear leukocytes at 1 wk (Fig. 1). These cells were predomi-
nantly in the region of the fornix, with occasional microabscesses. No changes
were seen in the renal parenchyma. At 4 wk, the pathologic picture had changed.
Predominant changes were found in the renal parenchyma. Collections of polymor-
phonuclear leukocytes were seen in the tubules in both cortex (Fig. 2) and
medulla. Necrotizing lesions with collection of polymorphonuclear leukocytes oblit-
erating the cortical architecture were not rare. Periarteriolar infiltration with mono-
uclear cells were frequently seen. Tubular atrophy and interstitial scarring were
noted.
From 8 to 32 wk, the pathologic picture was similar to that seen at 4 wk after
inoculation. The only changes were a progressive increase in the severity of the
lesions, and a relative increase in mononuclear infiltration; and the chronic lesions,
tubular atrophy, and interstitial scarring became more obvious. Colloid casts and
hyalinized glomeruli were seen only rarely. Acute lesions with intratubular masses
of polymorphs as well as areas of necrosis, however, were readily observed in about
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FIG. 2. Infected kidney, 4 wk. Section from renal cortex demonstrating intratubular collection
of polymorphonuclear leukocytes in the center of photograph. To the left, part of a poorly
delineated necrotizing abcess is observed. X 160.
half of the animals (Fig. 3) coexisting with chronic changes. Polymorph and mono-
nuclear cells were always observed in the renal pelvis.
Lesions in kidneys found to be noninfected at the time of harvest were variable.
On occasions, a few polymorphs were seen in the pelvic region. Moderate tubular
atrophy was seen in approximately one-fourth of the kidneys and rarely collections
of mononuclear cells were observed interstitially and around the vessels.
Measurement of the BUN showed that E. coli pyelonephritis leads to renal
impairment. The BUN of 16 control mice was 24.0 + 3.1 mg%. In 18 mice with
pyelonephritis the BUN was 41.0 + 5.0 mg%. In 26 animals which had been in-
jected with bacteria but had negative kidney cultures at sacrifice, the BUN was
36.7 ± 3.5 mg%. The BUN of mice with infection did not differ significantly
(P < .20) from the BUN of mice injected with E. coli and found to have sterile
kidneys at sacrifice. As indicated above, however, many of these kidneys showed
histologic changes consistent with moderate renal damage.
Antibody titers are shown in Table 2. Test animals which were bacteria-free
at sacrifice nevertheless demonstrated antibacterial antibody. When hemagglutina-
tion titers were compared overall, noninfected animals had significantly less anti-
body then infected animals (P < .001). On the other hand, agglutination titers
of noninfected were not significantly different from those of infected animals
(P > .90). Agglutination titers were higher than hemagglutination titers overall
(P < .01).
Ideally, serum bactericidal activity studies should have been done with the infect-
ing strain. However, the Yale strain of E. coli used in this study was not susceptible
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FIG. 3. Infected kidney, 32 wk. A large abscess in the lower half of photograph is observed.
Atrophic tubules containing casts associated with interstitial infiltration by mononuclear and
polymorphonuclear leukocytes are seen. x150.
to the bactericidal effect of serum with complement. It could not be made sero-
susceptible by treatment with diphenylamine (7). Therefore, in order to study
effect of infection on serum bactericidal activity, E. coli 0127:B8 (kindly supplied
by Dr. M. Landy) was used. This strain is known to be very susceptible to human
serum but we were unable to demonstrate any bactericidal activity of mouse serum
from infected or noninfected animals at the lowest dilutions tested, 1:32 to 1:64.
We were also unable to demonstrate antibody against homologous kidney saline ex-
tract or specific soluble substance at serum dilution of 1:40 in infected or nonin-
fected mice.
TABLE 2
ANTIBACTERIAL ANTIBODY RESPONSE AFTER INTRABLADDER INOCULATION OF
Escherichia coli YALE INTO MICE UNDERGOING DIunREsIs
Tinme of Hemagglutination Agglutination
sacrifice Infected Not infected Infected Not infected
(wk) at sacrificea at sacrifice at sacrifice at sacrifice
4 2.39 (6)b _ 2.81 (6)
8 2.12 (2) 2.36 (2)
12 1.90 (1) 0.00 (4) 3.11 (1) 3.03 (4)
16 2.51 (1) 1.25 (2) 3.11 (1) 2.81 (2)
20 2.56 (3) 0.00 (2) 3.91 (3) 2.81 (2)
24 2.81 (1) 0.00 (1) 2.81 (1) 1.20 (1)
28 1.60 (1) 0.45 (5) 3.41 (1) 3.17 (5)
32 2.51 (3) 2.55 (2) 2.05 (3) 2.81 (i)
Overall 2.39 ± 0.12 (16) 0.70 ± 0.20 (18) 2.92 ± 0.67 (16) 2.80 ± 0.07 (18)
a Bacteria present in one or both kidneys.
b Log geometric mean of reciprocal of serum dilution titer. The lowest serum dilution tested was
1:40. A negative at that dilution was scored zero. The number of animals tested is shown in
parentheses.E. coli PYELONEPHRITIS MICE
DISCUSSION
This study has confirmed and extended the observations of Keane and Freedman
(1). They showed that abscesses developed in the kidneys of mice when E. coli
was injected into the bladder of mice during diuresis and that bacteria were cul-
tured from the kidneys and urine up to 3 wk after infection. The present studies
show that bacteria persisted in kidneys and urine, progressive histological changes
of pyelonephritis occurred, and E. coli antibodies were elevated for the duration
of the study, 32 wk. This infection even when no longer present at time of sacrifice
as judged by the absence of bacteria, led to a moderate elevation of the BUN.
At 1 wk after infection histological lesions were seen in the renal pelvis. Others
have also noted the early lesions in the pelvis in experimental ascending pyelone-
phritis (10-12). Severe changes of pyelonephritis were observed 4 wk after infec-
tion with polymorphonuclear casts, necrotizing abscesses, mononuclear infiltration
together with moderate tubular atrophy, and interstitial scarring. These lesions per-
sited and progressed up to 32 wk. The pathological changes in the kidneys were
those of progressive pyelonephritis. Acute inflammation at 32 wk raised the possi-
bility that recurrent renal infection was occurring from infected bladder urine.
Immunologic studies indicated that agglutination titers did not distinguish be-
tween animals found to be infected and noninfected at sacrifice. This suggests that
the agglutinating antibody response may have been primarily to the original injec-
tion. On the other hand, it would appear that further antigenic stimulation sec-
ondary to infection was necessary for hemagglutinating antibody response. In any
case, presence of antibody did not eliminate the infection, as there was persistence
of infection in animals with a mean agglutinating titer of 1:840. In this respect
it was of interest that no bactericidal activity could be demonstrated in sera of
infected mice although, as indicated above, we could not test below 1:32 due to
lack of serum. The results of this study are similar to those reported from this
laboratory on elderly men with pyelonephritis where there was no relation between
antibody titer and serum bactericidal activity (4). Alternatively, the antibody pro-
duced might be potentially effective, but its activity is interfered with by the unique
metabolic milieu of the kidney as previously demonstrated (8).
Anti-tissue antibody was sought in this model because of the possibility of auto-
immune phenomena occurring in pyelonephritis. As was the result in man (9),
no antitissue antibody could be demonstrated.
Previous studies of experimental pyelonephritis with E. coli and other gram neg-
ative bacilli have required manipulation of the urinary tract in order for the infec-
tion to persist in the kidney. Manipulation of the kidney or urinary tract has usually
introduced some form of obstruction which itself has influenced host defense mech-
anisms and has made the study of immune mechanisms and virulence factors diffi-
cult to interpret. We feel that the present model of Keane and Freedman (1) more
nearly represents the ascending E. coli infection resulting in pyelonephritis that
is seen clinically and that this makes it a useful model to study the natural history
and the effects of therapy.
SUMMARY
The natural history of pyelonephritis produced by inoculation of E. coli into
the bladder of mice undergoing diuresis was studied for 32 wk. Bacteria were
present in half the kidneys in high numbers and persisted for the duration of the
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study. Early histological changes of pyelonephritis were seen at 1 wk after infection
with infiltration of the pelvic epithelium by polymorphonuclear leukocytes. Poly-
morphonuclear leukocyte casts, necrotizing abscesses, mononuclear infiltration to-
gether with tubular atrophy, and interstitial scarring had developed at 4 wk and
increased in severity up to 32 wk. The persistence of acute lesions until the thirty-
second week suggested that recurrent infection may have been occurring from a
reservoir of bacteria in bladder urine. The renal lesion resulted in a moderate eleva-
tion of the BUN (41.0 ± 5.0 mg% ). Serum agglutination titers did not distinguish
between animals found to be infected and noninfected at sacrifice. On the other
hand, hemagglutination titers of infected animals were significantly higher than
those which did not become infected.
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